However, monitoring patients with ENPP1 pathogenic variants for cutaneous or ophthalmologic PXE lesions is recommended, considering the common genetic variation in PXE and ARHR2 (5). The gene discussed is ENPP1; the disease is pseudoxanthoma elasticum (inherited or acquired).